Insider · CIK 0001378585

Scheer David

Reports to the SEC for 3 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001378585

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-01-28	ACHILLION PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−29.5K sh	$6.30	−$186K	0
2020-01-28	ACHILLION PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−63.2K sh	$6.30	−$398K	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42K sh	—	—	0
2019-11-13	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$3.28	+$65.6K	40,000
2019-11-13	ACHILLION PHARMACEUTICALS INCS Sale	Director	SSale	−10.5K sh	$6.31	−$66.2K	29,515
2019-11-13	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2019-01-23	ACHILLION PHARMACEUTICALS INCStock Option (Right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2018-12-14	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.05	+$21K	20,000
2018-12-14	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2018-02-09	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2017-01-19	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2016-11-29	Aegerion Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−521K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,988 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.9K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.7K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,012 sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2016-01-25	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2015-12-01	Aegerion Pharmaceuticals, Inc.J Other	Director	JOther	−1,855 sh	—	—	585,364
2015-12-01	Aegerion Pharmaceuticals, Inc.J Other	Director	JOther	−64K sh	—	—	521,350
2015-06-26	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2014-12-02	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2013-12-17	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2013-08-27	Aegerion Pharmaceuticals, Inc.J Other	Director	JOther	−32K sh	—	—	588,147
2013-08-27	Aegerion Pharmaceuticals, Inc.J Other	Director	JOther	−928 sh	—	—	587,219
2013-08-21	Aegerion Pharmaceuticals, Inc.S Sale	Director	SSale	−19.6K sh	$84.57	−$1.66M	620,554
2013-08-21	Aegerion Pharmaceuticals, Inc.S Sale	Director	SSale	−400 sh	$85.07	−$34K	620,154
2013-06-26	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+14.7K sh	—	—	14,700
2012-12-18	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-06-05	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.9K sh	—	—	12,854
2012-05-21	TENGION INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-12-12	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-09-28	TENGION INCStock Option (Right to Buy)A Award	Director	AAward	+4,700 sh	—	—	4,700
2011-06-01	Aegerion Pharmaceuticals, Inc.Common Stock (right to buy)A Award	Director	AAward	−9,988 sh	—	—	9,988
2011-03-11	Aegerion Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+6,006 sh	$15.36	+$92.3K	650,154
2011-03-10	Aegerion Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+3,994 sh	$15.11	+$60.3K	644,148
2010-12-16	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2010-04-14	TENGION INCP Purchase	Director	PPurchase	+20K sh	$5.00	+$100K	175,495
2010-04-14	TENGION INCC Conversion	Director	CConversion	+12.9K sh	—	—	188,389
2010-04-14	TENGION INCSeries A Convertible Preferred StockC Conversion	Director	CConversion	−132K sh	—	—	0
2010-04-14	TENGION INCSeries B Convertible Preferred StockC Conversion	Director	CConversion	−54.9K sh	—	—	0
2010-04-09	TENGION INCStock Option (Right to Buy)A Award	Director	AAward	+4,700 sh	—	—	4,700
2009-12-18	ACHILLION PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Jan 294
Scheer David0001562180-20-000675
SEC(opens sec.gov)
Nov 144
Scheer David0001562180-19-005523
SEC(opens sec.gov)
Jan 254
Scheer David0001209191-19-005380
SEC(opens sec.gov)
Dec 184
Scheer David0001209191-18-063175
SEC(opens sec.gov)
Feb 134
Scheer David0001209191-18-009656
SEC(opens sec.gov)
Jan 194
ACHILLION PHARMACEUTICALS INC0001209191-17-004620
SEC(opens sec.gov)
Nov 304
Aegerion Pharmaceuticals, Inc.0001104659-16-159822
SEC(opens sec.gov)

Companies

Address

C/O ACHILLION PHARMACEUTICALS 300 GEORGE STREET

NEW HAVEN, CT, 06511